Wladimir Hogenhuis
Chief Operating Officer, Ultragenyx Pharmaceutical Inc.
Companies
- Rezolute, Inc.Board member Mar 8, 2021 to now1
- Ultragenyx Pharmaceutical Inc.Chief operating officer Oct 5, 2018 to Oct 7, 20192
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Rezolute, Inc. RZLT119,675 shares3$442.2K at $3.69Dec 16, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 16, 2025Bought 5,650 shares at $1.69 of Rezolute, Inc.3
- Nov 19, 2025Granted 21,000 shares of Rezolute, Inc.4
- Jun 10, 2025Granted 9,000 shares of Rezolute, Inc.5
- Mar 31, 2025Bought 6,758 shares at $2.92 of Rezolute, Inc.6
- Feb 18, 2025Bought 10,000 shares at $4.70 of Rezolute, Inc.7
- Feb 16, 2025Granted 25,500 shares of Rezolute, Inc.7
- Sep 24, 2024Bought 4,259 shares at $4.70 of Rezolute, Inc.8
- Jun 25, 2024Bought 4,815 shares at $4.15 of Rezolute, Inc.9
- May 4, 2022Bought 25,000 shares at $3.80 of Rezolute, Inc.10
- Oct 15, 2021Bought 7,693 shares at $6.50 of Rezolute, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRezolute, Inc., Board member
- 2
- 3
- 4SEC EDGARForm 4 filed Nov 21, 2025
- 5SEC EDGARForm 4 filed Jun 13, 2025
- 6SEC EDGARForm 4 filed Apr 1, 2025
- 7SEC EDGARForm 4 filed Feb 20, 2025
- 8SEC EDGARForm 4 filed Sep 24, 2024
- 9SEC EDGARForm 4 filed Jun 27, 2024
- 10SEC EDGARForm 4 filed May 6, 2022